ARO-CFB

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameARO-CFB
Drug Alias NameARO-CFB
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionComplement factor B expression inhibitorsRNA interference
TargetsComplement factor B
Therapy Area/IndicationsGlomerulonephritis, IGALiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGA
Inactive IndicationsLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A